Navigation Links
First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin
Date:5/24/2011

MIAMI BEACH, Fla., May 24, 2011 /PRNewswire/ -- Benefiting from recent investments in production and enormous demand for its products, Divine Skin Inc. (DSKX), just reported another record quarter. The leading developer of topical biotechnology for hair growth posted Q1 sales of $2.25 million, up 126 percent over Q1 of 2010. It was the fastest growth since the company went public just over a year ago.

"Although Q1 delivered a stellar number — made possible by numerous improvements in logistics and fulfillment — we are not yet satisfied and certainly not resting on our accomplishments," said CEO Daniel Khesin. "Divine Skin can grow even faster, and coming quarters will be proof of that."

The company's best-selling shampoo and hair-growth treatments target androgenic alopecia, the most common type of hair loss, which afflicts almost 50 percent of white men over age 40.

"We have just scratched the surface of this enormous market; the potential is endless. With the four new distribution agreements just announced, I have no doubt that shareholders will be enormously satisfied for many years to come."

Khesin was referring to new agreements to sell the DS Laboratories line via four major distributors that supply 27,000 salons and beauty professionals around the United States:

  • Salon Services & Supplies, near Seattle, sells to 10,000 salons in Oregon, Idaho, Washington, and Utah.
  • Sweis, in Torrance, Calif., works with 7,000 salons and licensed professionals around Southern California and Las Vegas.
  • The Salon Center, of Birmingham, Ala., serves 7,000 salons in Florida, Georgia, Alabama, Louisiana, and Mississippi.
  • Salon Only Sales, in River Falls, Wis., serves 3,000 salons in Wisconsin, Minnesota, and Iowa.

The new deals were due largely to Robin Powell, the industry veteran who joined Divine Skin in January as head of global business devel
'/>"/>

SOURCE Divine Skin
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
2. Trubion Announces Dates for First-Quarter 2009 Earnings Conference Call
3. Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
4. Divine Skin Posts Record Sales for 2010: Up 55% Over 2009
5. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
6. China-Biotics Receives First U.S. Sales Order
7. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
8. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
9. Photonic Products Group, Inc. Announces New Sales and Marketing VP
10. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
11. Content Management and Life Sciences Software Veteran Joins Virtify as Vice President of Worldwide Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Clintrax ... services located in Raleigh, NC ... Evans as Vice President of Administration. ... will oversee all corporate processes, including their alignment ... Clintrax Global, Brad worked as an HR executive, ...
(Date:8/20/2014)... often have it that American Indians largely were wiped ... influenza and tuberculosis brought to the New World by ... 20 million people lived in the Americas shortly before ... killed by European diseases., But new research led by ... Johannes Krause of the University of Tubingen in Germany ...
(Date:8/20/2014)... Neurotrope, Inc. (OTCQB: NTRP) today announced ... provide an update on Company activities. Access information:Date:Tuesday, ... 505-4369 (U.S. and Canada) or (719) 325-2315 Conference ... under "Investor Relations"The teleconference replay will be available ... 2014 at (888) 203-1112 (U.S. and ...
(Date:8/20/2014)... 2014  Decision Resources Group finds that the vascular access device ... , India and China ... equal to the size of the United States ... experience much faster growth as a result of strong economic expansion, ... key findings from Decision Resources Group,s coverage of the BRIC vascular ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3
... Using bacteria to generate energy is a signifiant step ... University of East Anglia (UEA). Published today by ... Academy of Sciences (PNAS), the research demonstrates for ... proteins which enable bacterial cells to transfer electrical charge. ...
... 23, 2011 DATATRAK International, Inc. (OTCQX: DATA), a ... for the clinical trials industry, today announced the Company,s ... for the second consecutive year. "Being ... the hard work and dedication DATATRAK and its employees ...
... In the computer displays of medical equipment in hospitals ... major role. But a discovery reported from the University ... which have been found to change their ordering and ... low concentrations of a particular bacterial lipid, might find ...
Cached Biology Technology:Discovery opens the door to electricity from microbes 2DATATRAK Recognized as 2011 Crain's Leading EDGE Award Winner 2Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 2Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 3
(Date:8/20/2014)... Ore. -- When are athletes who have suffered concussions ... Oregon study has found that high school athletes who ... 60 days experience a significant regression in their abilities ... The regression, as seen in changes in their balance ... 19 athletes. Ten of the 12 had returned to ...
(Date:8/20/2014)... a burning spiciness that is irresistible to some, but ... are using their findings to develop a new drug ... caused by inflammation or other problems. They reported their ... clinical trials, in ACS, Journal of Medicinal Chemistry ... ago, scientists had pegged a compound called capsaicin as ...
(Date:8/20/2014)... chairs, synthetic rugs and plastic bags could one day ... rather than petroleum, scientists are now reporting. The novel ... the world deal with its agricultural and plastic waste ... , Athanassia Athanassiou, Ilker S. Bayer and colleagues at ... popularity is constantly growing. In 2012, its production reached ...
Breaking Biology News(10 mins):Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3
... Today,s opening of a new breast health center next ... significant research opportunities for the Translational Genomics Research Institute ... will include a tumor biorepository for TGen that will ... to diagnose and treat breast cancer, which affects 1 ...
... the results are receiving rave reviews from apple lovers. ... a new apple cultivar has been introduced by scientists ... New Jersey, and Indiana experiment stations. This high-quality dessert ... S. Korban, of the Department of Natural Resources and ...
... GREECETo grow the high-quality potted plants preferred by ... affect plant growth and development. The use of ... production of compact gardenia plants; the chemicals are ... the production of lateral shoots that create aesthetically ...
Cached Biology News:Breast health center gives TGen new research opportunities 2Apple enthusiasts welcome WineCrisp 2Photoselective film proves effective for controlling height in potted gardenia plants 2
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112...
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
7G10 anti-Fasciclin III...
Rabbit polyclonal to Nck alpha ( Abpromise for all tested applications). entrezGeneID: 4690 SwissProtID: P16333...
Biology Products: